无关紧要 发表于 2025-3-23 10:34:11
http://reply.papertrans.cn/17/1643/164274/164274_11.pngLUT 发表于 2025-3-23 15:35:09
Satyaprakash,Ayon K. Tarafdar,Ravi Guptaf, as is the case for retroviral vectors. To date, the methods of choice are those that use agents that do not integrate into the host genome. These include Sendai viral vectors, episomal vectors, protein transduction and RNA-based transfection.无聊的人 发表于 2025-3-23 18:18:22
http://reply.papertrans.cn/17/1643/164274/164274_13.png妈妈不开心 发表于 2025-3-24 01:55:36
http://reply.papertrans.cn/17/1643/164274/164274_14.png门窗的侧柱 发表于 2025-3-24 04:15:13
Christopher Chase-Dunn,Andrew Jorgensonnal plating density. Human embryonal carcinoma cells (hECCs), in contrast, can be grown as a monolayer, but when overconfluent, they spontaneously differentiate (Figs. 12.5, 12.6 and 12.7). Both mESC lines and hECC lines are often used as control cell lines for the assessment of stem cell-specific antibodies and gene expression.男生戴手铐 发表于 2025-3-24 08:50:39
http://reply.papertrans.cn/17/1643/164274/164274_16.png伦理学 发表于 2025-3-24 10:49:54
Inactivated Mouse and Human Fibroblasts,m is the system of choice. This chapter looks at the morphology of mouse and human feeder cells in order make a subjective assessment of the quality of the feeders and their suitability to support the growth and expansion of PSCs (Figs. 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8 and 3.9).LASH 发表于 2025-3-24 18:06:31
Human Embryonic Stem Cells,yonal carcinoma cells. These cells were shown to be pluripotent in nature through their ability to form teratomas in immunocompromised mice, composed of tissues derived from all three germ layers. The potential utilisation of these cells for disease modelling, toxicology studies and regenerative medicine heralded a new era in the field of biology.必死 发表于 2025-3-24 22:18:59
http://reply.papertrans.cn/17/1643/164274/164274_19.pngLicentious 发表于 2025-3-25 02:31:52
Derivation of Induced Pluripotent Stem Cells,f, as is the case for retroviral vectors. To date, the methods of choice are those that use agents that do not integrate into the host genome. These include Sendai viral vectors, episomal vectors, protein transduction and RNA-based transfection.